Original Article
Subject Category: Cell Therapy
Molecular Therapy (2009) 17 3, 562–569 doi:10.1038/mt.2008.289
Inhibition of Multidrug-resistant Acinetobacter baumannii by Nonviral Expression of hCAP-18 in a Bioengineered Human Skin Tissue
Christina L Thomas-Virnig1,2, John M Centanni2, Colette E Johnston2, Li-Ke He3, Sandy J Schlosser1, Kelly F Van Winkle2, Ruibing Chen4, Angela L Gibson5,6, Andrea Szilagyi3, Lingjun Li4, Ravi Shankar3 and B Lynn Allen-Hoffmann1
- 1Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison, Madison, Wisconsin, USA
- 2Stratatech Corporation, Madison, Wisconsin, USA
- 3Department of Surgery and Cell Biology, Neurobiology and Anatomy, Loyola University Medical Center, Maywood, Illinois, USA
- 4School of Pharmacy and Department of Chemistry, University of Wisconsin–Madison, Madison, Wisconsin, USA
- 5Program in Cellular and Molecular Biology, University of Wisconsin–Madison, Madison, Wisconsin, USA
- 6Medical Scientist Training Program, University of Wisconsin School of Medicine and Public Health, University of Wisconsin–Madison, Madison, Wisconsin, USA
Correspondence: B. Lynn Allen-Hoffmann, Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison, 5605 Medical Sciences Center, 1300 University Avenue, Madison, Wisconsin 53706-1102, USA. E-mail: blallenh@wisc.edu
The first two authors contributed equally to this work.
Received 4 April 2008; Accepted 25 November 2008; Published online 3 February 2009.
Abstract
When skin is compromised, a cascade of signals initiates the rapid repair of the epidermis to prevent fluid loss and provide defense against invading microbes. During this response, keratinocytes produce host defense peptides (HDPs) that have antimicrobial activity against a diverse set of pathogens. Using nonviral vectors we have genetically modified the novel, nontumorigenic, pathogen-free human keratinocyte progenitor cell line (NIKS) to express the human cathelicidin HDP in a tissue-specific manner. NIKS skin tissue that expresses elevated levels of cathelicidin possesses key histological features of normal epidermis and displays enhanced antimicrobial activity against bacteria in vitro. Moreover, in an in vivo infected burn wound model, this tissue results in a two log reduction in a clinical isolate of multidrug-resistant Acinetobacter baumannii. Taken together, these results suggest that this genetically engineered human tissue could be applied to burns and ulcers to counteract bacterial contamination and prevent infection.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Shigellae control the Gates of LLNature Medicine News and Views (01 Feb 2001)
Fighting infections with vitamin DNature Medicine News and Views (01 Apr 2006)
RESEARCH
Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infectionsGene Therapy Research Article
In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37Journal of Investigative Dermatology Original Article
See all 24 matches for Research
